An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy ...

A large study of over 185,000 adults with type 2 diabetes found that GLP-1 receptor agonist use was linked to a slight ...

Researchers suggest all diabetes patients on weight-loss drugs should be regularly screened and monitored for potential eye ...

Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these ...

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...

A new study by researchers at Unity Health, Sunnybrook Health Sciences Centre and the University of Toronto has found that ...

MUSCAT: The National Programme for Early Detection of Diabetic Retinopathy using artificial intelligence (AI) technologies ...

This phase 2b/3 trial follows new, positive 2-year data from the phase 2 ALTITUDE trial, in which sura-vec was well-tolerated ...

Diabetic retinopathy may not cause any symptoms in its early stages, but as the disease progresses, you may experience changes to your vision, including: Blurred vision Vision that fluctuates ...

The Sultanate of Oman is the third country worldwide to implement this project, confirming its commitment to technological ...